Vec­tor Labs de­cou­ples from Mar­a­vai, pop­ping up shop with pri­vate cap­i­tal, new CEO on board

Vec­tor Lab­o­ra­to­ries has been in busi­ness since the 1970s, de­vel­op­ing and man­u­fac­tur­ing pro­tein de­tec­tion to help study tis­sues and cells. Af­ter Tues­day, the team will do so as a stand-alone com­pa­ny flush with pri­vate cap­i­tal and head­ed by a new CEO.

Vec­tor an­nounced a $124 mil­lion cash buy­out backed by pri­vate eq­ui­ty firm Thomp­son Street Cap­i­tal Part­ners on Tues­day to fund its ex­pan­sion in pro­tein de­tec­tion. The mon­ey will help Vec­tor with fu­ture merg­ers and ac­qui­si­tions, and help com­mer­cial­ize its la­bel­ing and de­tec­tion tech­nol­o­gy in its pipeline.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER